questionsmedicales.fr
Structures virales
Virion
Virion : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Tests de diagnostic
Virion
Microscopie électronique
Virus
Tests sérologiques
Anticorps
Symptômes
5
Infection virale
Symptômes
Variabilité des symptômes
Virus
Période d'incubation
Infection virale
Symptômes neurologiques
Virus
Prévention
5
Masques
Transmission virale
Hygiène personnelle
Prévention
Traitements
5
Antibiotiques
Infection virale
Traitement symptomatique
Infection virale
Résistance virale
Antiviraux
Complications
5
Complications
Infection virale
Maladies chroniques
Virus
Gestion des complications
Traitement
Variabilité des complications
Virus
Facteurs de risque
5
Facteurs de risque
Infection virale
Stress
Système immunitaire
Maladies chroniques
Infection virale
Environnement
Infection virale
Habitudes alimentaires
Système immunitaire
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Virion : Questions médicales les plus fréquentes",
"headline": "Virion : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Virion : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-12",
"dateModified": "2025-03-09",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Virion"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Structures virales",
"url": "https://questionsmedicales.fr/mesh/D056224",
"about": {
"@type": "MedicalCondition",
"name": "Structures virales",
"code": {
"@type": "MedicalCode",
"code": "D056224",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A21"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Nucléocapside",
"alternateName": "Nucleocapsid",
"url": "https://questionsmedicales.fr/mesh/D019251",
"about": {
"@type": "MedicalCondition",
"name": "Nucléocapside",
"code": {
"@type": "MedicalCode",
"code": "D019251",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A21.249.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Capside",
"alternateName": "Capsid",
"url": "https://questionsmedicales.fr/mesh/D002213",
"about": {
"@type": "MedicalCondition",
"name": "Capside",
"code": {
"@type": "MedicalCode",
"code": "D002213",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A21.249.500.250"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Enveloppe virale",
"alternateName": "Viral Envelope",
"url": "https://questionsmedicales.fr/mesh/D000086942",
"about": {
"@type": "MedicalCondition",
"name": "Enveloppe virale",
"code": {
"@type": "MedicalCode",
"code": "D000086942",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A21.249.750"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Virion",
"alternateName": "Virion",
"code": {
"@type": "MedicalCode",
"code": "D014771",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Tibor Füzik",
"url": "https://questionsmedicales.fr/author/Tibor%20F%C3%BCzik",
"affiliation": {
"@type": "Organization",
"name": "Structural Virology Group, Central European Institute of Technology, Masaryk University, Kamenice 753/5, 62500 Brno, Czech Republic."
}
},
{
"@type": "Person",
"name": "Pavel Plevka",
"url": "https://questionsmedicales.fr/author/Pavel%20Plevka",
"affiliation": {
"@type": "Organization",
"name": "Structural Virology Group, Central European Institute of Technology, Masaryk University, Kamenice 753/5, 62500 Brno, Czech Republic pavel.plevka@ceitec.muni.cz."
}
},
{
"@type": "Person",
"name": "Liya Mukhamedova",
"url": "https://questionsmedicales.fr/author/Liya%20Mukhamedova",
"affiliation": {
"@type": "Organization",
"name": "Structural Virology Group, Central European Institute of Technology, Masaryk University, Kamenice 753/5, 62500 Brno, Czech Republic."
}
},
{
"@type": "Person",
"name": "Antonín Přidal",
"url": "https://questionsmedicales.fr/author/Anton%C3%ADn%20P%C5%99idal",
"affiliation": {
"@type": "Organization",
"name": "Department of Zoology, Fishery, Hydrobiology, and Apidology, Faculty of Agronomy, Mendel University in Brno, Zemědělská 1/1665, 613 00 Brno, Czech Republic."
}
},
{
"@type": "Person",
"name": "Michael Way",
"url": "https://questionsmedicales.fr/author/Michael%20Way",
"affiliation": {
"@type": "Organization",
"name": "Cellular Signalling and Cytoskeletal Function Laboratory, The Francis Crick Institute, London, United Kingdom."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Population pharmacokinetics of tenofovir given as either tenofovir disoproxil fumarate or tenofovir alafenamide in an African population.",
"datePublished": "2023-04-04",
"url": "https://questionsmedicales.fr/article/37013631",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/psp4.12955"
}
},
{
"@type": "ScholarlyArticle",
"name": "Retreatment Efficacy and Renal Safety of Tenofovir Alafenamide, Entecavir, and Tenofovir Disoproxil Fumarate After Entecavir or Tenofovir Cessation.",
"datePublished": "2022-08-17",
"url": "https://questionsmedicales.fr/article/35976597",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10620-022-07657-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Chemoenzymatic Synthesis of Tenofovir.",
"datePublished": "2023-07-19",
"url": "https://questionsmedicales.fr/article/37467462",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acs.joc.3c01005"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Use of Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide for Preventing Vertical Transmission of Hepatitis B.",
"datePublished": "2023-02-01",
"url": "https://questionsmedicales.fr/article/36598804",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/MCG.0000000000001785"
}
},
{
"@type": "ScholarlyArticle",
"name": "Safety of tenofovir alafenamide in people with HIV who experienced proximal renal tubulopathy on tenofovir disoproxil.",
"datePublished": "2024-06-27",
"url": "https://questionsmedicales.fr/article/38932750",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/QAD.0000000000003916"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Structures virales",
"item": "https://questionsmedicales.fr/mesh/D056224"
},
{
"@type": "ListItem",
"position": 3,
"name": "Virion",
"item": "https://questionsmedicales.fr/mesh/D014771"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Virion - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Virion",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-02",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Virion",
"description": "Comment identifier un virion dans un échantillon ?\nQuels tests sont utilisés pour détecter les virions ?\nLes virions peuvent-ils être visualisés au microscope ?\nQuelle est la méthode de culture des virions ?\nLes tests sérologiques détectent-ils les virions ?",
"url": "https://questionsmedicales.fr/mesh/D014771?mesh_terms=Tenofovir#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Virion",
"description": "Quels symptômes indiquent une infection virale ?\nLes virions causent-ils toujours des symptômes ?\nComment les symptômes varient-ils selon le virion ?\nLes symptômes d'une infection virale sont-ils immédiats ?\nLes virions peuvent-ils provoquer des symptômes neurologiques ?",
"url": "https://questionsmedicales.fr/mesh/D014771?mesh_terms=Tenofovir#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Virion",
"description": "Comment prévenir les infections virales ?\nLes masques protègent-ils contre les virions ?\nLes vaccins sont-ils efficaces contre tous les virions ?\nL'hygiène personnelle aide-t-elle à prévenir les infections ?\nLes voyages augmentent-ils le risque d'infection virale ?",
"url": "https://questionsmedicales.fr/mesh/D014771?mesh_terms=Tenofovir#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Virion",
"description": "Quels traitements sont efficaces contre les virions ?\nLes antibiotiques sont-ils efficaces contre les virions ?\nComment les vaccins agissent-ils contre les virions ?\nLes traitements symptomatiques sont-ils utiles ?\nLes traitements antiviraux sont-ils toujours efficaces ?",
"url": "https://questionsmedicales.fr/mesh/D014771?mesh_terms=Tenofovir#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Virion",
"description": "Quelles complications peuvent survenir après une infection virale ?\nLes virions peuvent-ils causer des maladies chroniques ?\nComment les complications sont-elles gérées ?\nLes complications varient-elles selon le virion ?\nLes enfants sont-ils plus à risque de complications ?",
"url": "https://questionsmedicales.fr/mesh/D014771?mesh_terms=Tenofovir#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Virion",
"description": "Quels sont les facteurs de risque d'infection virale ?\nLe stress affecte-t-il le risque d'infection virale ?\nLes maladies chroniques augmentent-elles le risque d'infection ?\nL'environnement joue-t-il un rôle dans le risque viral ?\nLes habitudes alimentaires influencent-elles le risque viral ?",
"url": "https://questionsmedicales.fr/mesh/D014771?mesh_terms=Tenofovir#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier un virion dans un échantillon ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'identification se fait par microscopie électronique ou tests PCR."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les virions ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests PCR, les cultures virales et les tests sérologiques sont courants."
}
},
{
"@type": "Question",
"name": "Les virions peuvent-ils être visualisés au microscope ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les virions peuvent être visualisés au microscope électronique."
}
},
{
"@type": "Question",
"name": "Quelle est la méthode de culture des virions ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les virions sont cultivés dans des cellules hôtes appropriées en laboratoire."
}
},
{
"@type": "Question",
"name": "Les tests sérologiques détectent-ils les virions ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, ils détectent les anticorps contre les virions, pas les virions eux-mêmes."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une infection virale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, fatigue, douleurs musculaires et symptômes respiratoires sont fréquents."
}
},
{
"@type": "Question",
"name": "Les virions causent-ils toujours des symptômes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, certains virions peuvent être asymptomatiques chez l'hôte."
}
},
{
"@type": "Question",
"name": "Comment les symptômes varient-ils selon le virion ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes dépendent du type de virus et de l'hôte infecté."
}
},
{
"@type": "Question",
"name": "Les symptômes d'une infection virale sont-ils immédiats ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, il peut y avoir une période d'incubation avant l'apparition des symptômes."
}
},
{
"@type": "Question",
"name": "Les virions peuvent-ils provoquer des symptômes neurologiques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains virions, comme ceux de la grippe, peuvent affecter le système nerveux."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections virales ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Se laver les mains, éviter les contacts étroits et se faire vacciner sont essentiels."
}
},
{
"@type": "Question",
"name": "Les masques protègent-ils contre les virions ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les masques réduisent la transmission des virions par voie respiratoire."
}
},
{
"@type": "Question",
"name": "Les vaccins sont-ils efficaces contre tous les virions ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, chaque vaccin cible des virions spécifiques et ne protège pas contre tous."
}
},
{
"@type": "Question",
"name": "L'hygiène personnelle aide-t-elle à prévenir les infections ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une bonne hygiène personnelle réduit le risque d'infections virales."
}
},
{
"@type": "Question",
"name": "Les voyages augmentent-ils le risque d'infection virale ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyages peuvent exposer à de nouveaux virions et augmenter le risque d'infection."
}
},
{
"@type": "Question",
"name": "Quels traitements sont efficaces contre les virions ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antiviraux, comme l'oseltamivir, sont utilisés pour traiter certaines infections virales."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils efficaces contre les virions ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne sont pas efficaces contre les infections virales."
}
},
{
"@type": "Question",
"name": "Comment les vaccins agissent-ils contre les virions ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccins stimulent le système immunitaire à reconnaître et combattre les virions."
}
},
{
"@type": "Question",
"name": "Les traitements symptomatiques sont-ils utiles ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils aident à soulager les symptômes, mais ne traitent pas l'infection virale."
}
},
{
"@type": "Question",
"name": "Les traitements antiviraux sont-ils toujours efficaces ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, leur efficacité dépend du type de virus et de la résistance virale."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une infection virale ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme la pneumonie, la déshydratation ou des infections secondaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les virions peuvent-ils causer des maladies chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains virions, comme le VIH, peuvent entraîner des maladies chroniques."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles gérées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications sont gérées par des traitements symptomatiques et des soins médicaux appropriés."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon le virion ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque virion peut entraîner des complications différentes selon l'hôte."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus à risque de complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants peuvent être plus vulnérables aux complications des infections virales."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'infection virale ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, le système immunitaire affaibli et l'exposition à des porteurs."
}
},
{
"@type": "Question",
"name": "Le stress affecte-t-il le risque d'infection virale ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut affaiblir le système immunitaire et augmenter le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques augmentent-elles le risque d'infection ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les maladies chroniques peuvent affaiblir l'immunité et augmenter le risque d'infection virale."
}
},
{
"@type": "Question",
"name": "L'environnement joue-t-il un rôle dans le risque viral ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des environnements surpeuplés ou insalubres augmentent le risque d'infections virales."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles le risque viral ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation déséquilibrée peut affaiblir le système immunitaire et augmenter le risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 09/03/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Structural Virology Group, Central European Institute of Technology, Masaryk University, Kamenice 753/5, 62500 Brno, Czech Republic.
Publications dans "Virion" :
3 publications dans cette catégorie
Affiliations :
Structural Virology Group, Central European Institute of Technology, Masaryk University, Kamenice 753/5, 62500 Brno, Czech Republic pavel.plevka@ceitec.muni.cz.
Publications dans "Virion" :
2 publications dans cette catégorie
Affiliations :
Structural Virology Group, Central European Institute of Technology, Masaryk University, Kamenice 753/5, 62500 Brno, Czech Republic.
Publications dans "Virion" :
2 publications dans cette catégorie
Affiliations :
Department of Zoology, Fishery, Hydrobiology, and Apidology, Faculty of Agronomy, Mendel University in Brno, Zemědělská 1/1665, 613 00 Brno, Czech Republic.
Publications dans "Virion" :
2 publications dans cette catégorie
Affiliations :
Cellular Signalling and Cytoskeletal Function Laboratory, The Francis Crick Institute, London, United Kingdom.
Department of Infectious Disease, Imperial College, London, United Kingdom.
Publications dans "Virion" :
2 publications dans cette catégorie
Affiliations :
Central European Institute of Technology, Masaryk University, Kamenice 753/5, Brno, 625 00, Czech Republic.
Publications dans "Virion" :
2 publications dans cette catégorie
Affiliations :
Waksman Institute for Microbiology, Rutgers, The State University of New Jersey, Piscataway, NJ, 08854, USA.
Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, 19107, USA.
Publications dans "Virion" :
2 publications dans cette catégorie
Affiliations :
Department of Cell Biology and Neuroscience, Rowan University School of Osteopathic Medicine at Stratford, Stratford, NJ, 08084-1489, USA.
Publications dans "Virion" :
2 publications dans cette catégorie
Affiliations :
National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD, 20894, USA.
Publications dans "Virion" :
2 publications dans cette catégorie
Affiliations :
National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD, 20894, USA.
Publications dans "Virion" :
2 publications dans cette catégorie
Affiliations :
Center of Life Sciences, Skolkovo Institute of Science and Technology, Moscow, 121205, Russia. maria.sokolova@mpinat.mpg.de.
Department of Molecular Biology, Max Planck Institute for Multidisciplinary Sciences, Göttingen, 37077, Germany. maria.sokolova@mpinat.mpg.de.
Publications dans "Virion" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology & Cell Biology, Montana State Universitygrid.41891.35, Bozeman, Montana, USA.
Publications dans "Virion" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology & Cell Biology, Montana State Universitygrid.41891.35, Bozeman, Montana, USA.
Publications dans "Virion" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology & Cell Biology, Montana State Universitygrid.41891.35, Bozeman, Montana, USA.
Publications dans "Virion" :
2 publications dans cette catégorie
Affiliations :
Weizmann Institute of Science, Rehovot 7610001, Israel.
Publications dans "Virion" :
2 publications dans cette catégorie
Affiliations :
Weizmann Institute of Science, Rehovot 7610001, Israel.
Publications dans "Virion" :
2 publications dans cette catégorie
Affiliations :
Weizmann Institute of Science, Rehovot 7610001, Israel.
Publications dans "Virion" :
2 publications dans cette catégorie
Affiliations :
California Institute of Technology, Pasadena, CA 91125, USA.
Publications dans "Virion" :
2 publications dans cette catégorie
Affiliations :
California Institute of Technology, Pasadena, CA 91125, USA.
Chan Zuckerberg Biohub, 499 Illinois Street, SF CA 94158, USA.
Publications dans "Virion" :
2 publications dans cette catégorie
Affiliations :
Weizmann Institute of Science, Rehovot 7610001, Israel.
Publications dans "Virion" :
Tenofovir disoproxil fumarate (TDF) and tenofovir alafenamide (TAF) are prodrugs of the nucleotide analogue tenofovir, which acts intracellularly to inhibit HIV replication. Whereas TDF converts to te...
We aimed to compare the one-year retreatment efficacy and renal safety of entecavir, tenofovir disoproxil fumarate (TDF), and tenofovir alafenamide (TAF) after HBV relapse in patients who discontinued...
This retrospective study included 289 chronic hepatitis B (CHB) patients without cirrhosis who received entecavir (n = 93), TDF (n = 103), or TAF (n = 86) retreatment for at least 12 months after ente...
The rate of virological response (HBV DNA < 20 IU/mL) at 12 months of retreatment was 79/93 (84.9%) in the entecavir group, 92/103 (89.3%) in the TDF group, and 72/86 (83.7%) in the TAF group. The rat...
TAF could be one of the retreatment options for retreatment of HBV relapse after entecavir or TDF cessation....
We report on novel chemoenzymatic routes toward tenofovir using low-cost starting materials and commercial or homemade enzyme preparations as biocatalysts. The biocatalytic key step was accomplished e...
Mother-to-child transmission (MTCT) of hepatitis B virus may occur in highly viremic mothers despite the infants receiving appropriate immunoprophylaxis. We aimed to review tenofovir disoproxil fumara...
We performed a systematic review between January 1, 2015 and December 31, 2021 on PUBMED, EMBASE, Cochrane, CNKI, and Wanfang databases. Data was extracted from randomized controlled trials or cohort ...
Data from forty-three studies (13 randomized controlled trials, 30 nonrandomized studies) were included in the review. All infants in the studies received appropriate immunoprophylaxis. Among 3656 hig...
TDF is well established for preventing MTCT in highly viremic mothers, whereas TAF may become an option as data emerges....
Twenty-eight individuals who experienced proximal renal tubulopathy (PRT, Fanconi syndrome) while receiving tenofovir disoproxil initiated tenofovir alafenamide (TAF) and were followed for 5 years. No...
We aimed to compare the effects of P-glycoprotein (ABCB1) on the intestinal uptake of tenofovir disoproxil fumarate (TDF), tenofovir alafenamide fumarate (TAF), and metabolites, tenofovir isoproxil mo...
Bidirectional transport experiments in Caco-2 cells and accumulation studies in precision-cut intestinal slices prepared from the ileal segment of rodent (rPCIS) and human (hPCIS) intestines were perf...
TDF and TAF were extensively metabolised but TAF exhibited greater stability. ABCB1 significantly reduced the intestinal transepithelial transfer and uptake of the TFV...
TDF and TAF likely produce comparable concentrations of TFV-equivalents in the portal vein and the extent of permeation is reduced by the activity of ABCB1. DDI on ABCB1 can thus potentially affect TD...
Tenofovir alafenamide (TAF) is a novel prodrug of tenofovir for the treatment of chronic hepatitis B (CHB) infection. We aimed to evaluate the impact of switching to TAF on alanine aminotransferase (A...
We estimated list and net prices for tenofovir disoproxil fumarate (TDF) products Truvada, Complera, and Stribild, and their tenofovir alafenamide (TAF) versions Descovy, Odefsey, and Genvoya. Gilead ...
BACKGROUND Taiwan has a high prevalence of hepatitis B virus (HBV) infection. HBV-related end-stage liver disease is the leading cause of liver transplantation (LT). Tenofovir alafenamide (TAF) is a r...
Tenofovir disoproxil (TD), modified from tenofovir disoproxil fumarate (TDF), was developed as a salt-free formulation, removing fumarate to improve the ease of oral intake by reducing the tablet's si...
CHB patients with HBV-DNA <69 IU/mL after ≥24 weeks of TDF therapy were enrolled. The primary efficacy endpoint was the HBV-DNA suppression rate (HBV-DNA <69 IU/mL) at week 48; We evaluated the non-in...
Overall, 189 subjects were randomized in a 2:1 ratio, and 117 and 66 subjects in the TD and TDF groups, respectively, completed the study. In the per-protocol set, the HBV-DNA suppression rate at week...
TD was non-inferior to TDF for maintaining viral suppression in CHB patients, showing the less decline of renal function....